Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (VISIOTRAIN)

25 juli 2018 bijgewerkt door: Hospices Civils de Lyon

Cortical Visual Field Defects (CFVD) are common after acquired brain injury. They often cause problems with reading and visual exploration which impact on patients' quality of life. Apart from the substitutive method that uses prisms directly placed on glasses, two main rehabilitative methods have been explored previously: one restorative and one compensatory. The most effective methods seem to be based on compensatory training paradigms that target eye movements. They rely on voluntary mass-practice that induces changes in exploratory saccadic behaviour, particularly into the blind hemifield. Previous studies using this method have shown changes in visual scanning patterns but with only a marginal profit in terms of functional benefit.

In the present study, the investigators developed a new approach to the compensatory visual field training based solely on a bottom-up mechanism. It does not require the patients' ability to voluntarily maintain attention oriented to the affected field, which may be difficult for brain-damaged patients. As previously reported in other pathological contexts (e.g. use of prism adaptation or sensory stimulation in neglect patients), bypassing voluntary and conscious implication of the patient can produce improvements by a more automatic process.

The investigators hypotheses are: 1) that a novel ramp-step search paradigm can be used by hemianopic patients to automatically improve targeted eye movements into their blind visual field; and 2) that this will lead to behavioural improvements on ecologically valid tests of visual search.

Studie Overzicht

Toestand

Voltooid

Studietype

Ingrijpend

Inschrijving (Werkelijk)

22

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Saint Genis Laval, Frankrijk, 69235
        • Service de Médecine Physique et de Réadaptation,Hôpital Henry Gabrielle

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 80 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Male/Female
  • Stroke (ischemia or hemorrhage) documented by CTscan or MRI
  • Traumatic brain injury (TBI) documented by CTscan or MRI
  • Right or Left hemianopia defined by perimetry
  • All subjects must be between the ages of 18-80
  • Aetiology of visual field defect : Stroke (ischemia or hemorrhage)
  • Delay post-stroke : at least 6 months
  • Only one lesion on CTscan or MRI (performed in a maximal delay of 6 months)
  • Corrected monocular visual acuity > 5/10
  • Possible understanding of experimental conditions
  • Patient being able to be quiet and sit during at least 2 hours
  • Having given written informed consent prior to any procedure related to the study
  • Availability for the period of the study
  • Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research

Exclusion Criteria:

  • Ophthalmologic criteria : monocular visual acuity < 4/10, strabismus , diplopia , ocular instability , nystagmus, maculopathy , glaucoma , retinopathy , orthoptic rehabilitation
  • Neurologic criteria : sever phasic disturbances , neurologic degenerative affection , non controlled seizure , severe handicap non compatible with prolonged sit position or concentration during 30 consecutive minutes
  • No command of french language
  • Non stabilized medical situation
  • Females who are pregnant, nursing, or planning a pregnancy during the study period, or females of childbearing potential, not using a reliable means of contraception.
  • Not under any administrative or legal supervision

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ander
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Crossover-opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Arm 1:Treatment A
Treatment A (active) followed by treatment B (neutral)

The computer-based training task consists of a novel ramp-step search paradigm with a stimulus traversing the screen from left to right or right to left. Subjects are asked to pursue the stimulus (ramp phase) and then saccade to find its location when it suddenly jumps (step phase). The stimulus is an open spinning circle. At the end of each movement, the gap can be located at the top or at the bottom, and patients are asked to indicate this location by pushing the response button as quickly as possible.

The starting point will alternate between left and right. The training task includes 3 sessions with 100 movements each. Reaction Times and errors will be monitored online to ensure that the patient performs the task correctly.

Each treatment phase has the same pattern:

  • two visits in pre-tests evaluation (V1 and V2),
  • one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
  • two visits after treatment (V4 at one week and V5 at one month).
Experimenteel: Arm 2: Treatment B
Treatment B (neutral) followed by treatment A (active)

Placebo treatment using the same computer-based training task, but including only the ramp phase.

Each treatment phase has the same pattern:

  • two visits in pre-tests evaluation (V1 and V2),
  • one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
  • two visits after treatment (V4 at one week and V5 at one month).

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Difference in performance (mean reaction time - RT) of an ecological visual search task between pre-tests and immediate post-test for each patient according to treatment (A or B).
Tijdsspanne: 1 week
1 week

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Errors and omissions at each evaluation session for the visual search task
Tijdsspanne: 1, 2 and 5 weeks
Mean RT difference, errors and omissions at several visual tasks (rapid scanning task, exploratory visual tasks, reading task) at each evaluation session Parameters of visual field perimetry before and after treatment Oculo-motor parameters during the different tasks (i.e. amplitude and latencies for saccades and fixations)
1, 2 and 5 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Sophie Jacquin-Courtois, MD, PhD, Service de Médecine Physique et de Réadaptation

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

29 november 2010

Primaire voltooiing (Werkelijk)

13 juni 2018

Studie voltooiing (Werkelijk)

13 juni 2018

Studieregistratiedata

Eerst ingediend

15 november 2012

Eerst ingediend dat voldeed aan de QC-criteria

20 november 2012

Eerst geplaatst (Schatting)

21 november 2012

Updates van studierecords

Laatste update geplaatst (Werkelijk)

26 juli 2018

Laatste update ingediend die voldeed aan QC-criteria

25 juli 2018

Laatst geverifieerd

1 juli 2018

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2010.615
  • 2010-A00702-37 (Andere identificatie: ID-RCB)

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Treatment A

3
Abonneren